Single dose study of KLA480 in healthy volunteers
This trial tests a single dose of KLA480 in healthy adults to see how the body processes it. It may help researchers understand the drug's safety and potential benefits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You must be in good general health, with no serious medical conditions.
- Women must weigh at least 99 pounds (45 kg) and men at least 110 pounds (50 kg), with a BMI between 18 and 28.
- You cannot be allergic to rotigotine or similar drugs like pramipexole or ropinirole.
- You must not have donated blood or lost a large amount of blood in the past 3 months.
- You must agree to use effective birth control and not donate sperm or eggs for 3 months after the dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
This study tests a new drug called KLA318-2 in healthy volunteers to see how it is processed by the body and how safe it is. It is a first-in-human trial, so it helps find the right dose and check for any side effects.
This study tests the safety and how the body processes a new drug called AK0406 in healthy adults. If you are generally healthy and match the age and weight requirements, you may be able to help researchers understand if the drug is safe before it is tested in people with a medical condition.
This study tests a new drug called KLA478 for the first time in humans. It is looking for healthy volunteers to see how the drug affects the body and how safe it is.
This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.
This trial tests a new investigational drug for the first time in people. It will study how the drug is processed by the body in healthy volunteers. If you are a generally healthy adult, you may be able to help with this important early research.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.